Bristol picks ZS to handle commercial analytics in vendor consolidation move

Bristol-Myers Squibb ($BMY) has selected ZS to support its commercial analytics. The deal makes ZS Bristol's primary vendor in the sector, allowing the Big Pharma to trim the list of vendors with which it works to analyze commercial data. ZS won the contract on the strength of its 20-year working relationship with Bristol and capabilities of its Analytics Process Optimization tool. Release